Pancreatic cancer is one of the most complex and challenging cancers to treat due to the fact that symptoms are rarely present in early stages. As a result, Pancreatic cancer is usually diagnosed at a late stage and, typically, only ten to fifteen percent of pancreatic cancers are diagnosed when the patients are candidates for surgery.
Patients with pancreatic tumors frequently require several different kinds of treatment. The physicians in the pancreatic cancer team work together to provide a comprehensive and personalized treatment plan for each patient.
Patients with pancreatic tumors frequently require several different types of treatment.
Pancreatic Cancer Screening
Since the incidence of pancreatic cancer in the general population is low, with a life time risk of 1.3%, screening is not recommended for the general population. However, it is recommended for individuals considered to be at high risk of developing pancreatic cancer. High Risk individuals include:
- Patients with a family history of Pancreatic Cancer
- Genetic Mutation Carriers (Patients with: Peutz–Jeghers syndrome, familial atypical multiple mole melanoma syndrome, Lynch syndrome)
- Patients with Hereditary Pancreatitis
Screening should only be offered to individuals who are candidates for surgery.
Pancreatitis is inflammation, or irritation of the pancreas. This condition usually begins as a sudden episode known as acute pancreatitis and, in some cases, may result in long-term damage after severe and/or recurrent attacks, known as chronic pancreatitis. Mild cases of pancreatitis may go away without treatment, but severe cases can cause life threatening complications, such as the formation of a pseudocyst infection, malnutrition and pancreatic cancer.